BIOMAT Database Logo BIOMAT Database Logo

[Septrin in urinary tract infections. Clinical assessment]. 1971

G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
[Sensitivity to Septrin of microorganisms causing urinary tract infections].
October 1972, Polski tygodnik lekarski (Warsaw, Poland : 1960),
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
[Our experience with Septrin in the therapy of urinary tract infections in chldren].
April 1973, Ceskoslovenska pediatrie,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
[Clinical manifestations of urinary tract infections. III. Kidney function disorders in urinary tract infections].
April 1957, Deutsche medizinische Wochenschrift (1946),
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
[Clinical evaluation of antimicrobial agents in urinary tract infections (urinary tract infections in paraplegics. II)].
July 1967, Hinyokika kiyo. Acta urologica Japonica,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
The use of 'Septrin' in the treatment of upper respiratory-tract infections.
December 1970, The Practitioner,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
Assessment of gentamicin sulphate in urinary tract infections.
January 1969, The British journal of clinical practice,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
Clinical management of urinary tract infections.
February 1952, The Journal of the Arkansas Medical Society,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
Clinical Management of Urinary Tract Infections.
April 2016, Pediatric annals,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
[Clinical aspects of urinary tract infections].
February 1987, Soins; la revue de reference infirmiere,
G Brauner, and K Kloczkowski, and A Prelich, and K Stapor, and B Augustyniak, and A Ganczarski
[A clinical evaluation of nalidixic acid in the urinary tract infections (urinary tract infections in paraplegics. I)].
July 1967, Hinyokika kiyo. Acta urologica Japonica,
Copied contents to your clipboard!